Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …

Nearly one million people in the U.S. are living with Parkinson’s Disease. Playhouse Square is rolling out a new program to help a growing number of patients.It’s important outreach because the number of cases in the U.S. is expected to rise to 1.2 million over the next five years.Last month, I circled back with the

1WorldSync’s 2024 Consumer Product Content Benchmark report revealed that 64% of shoppers have scanned a QR code on a product while shopping in-store. With a quick click on a smartphone, these customers have accessed hidden content, exclusive deals and lightning-fast checkouts. The result? Static shelves are morphing into dynamic, interactive …